Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Other Operating Expenses (2021 - 2026)

Invivyd's (IVVD) quarterly Other Operating Expenses came in at $1.3 million in Q2 2026, up 85.84% on a YoY basis from $685000.0 in Q2 2025, and up 11.67% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Invivyd (IVVD) Other Operating Expenses (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Other Operating Expenses for 6 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Operating Expenses rose 85.84% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 37.29% YoY), and the FY2025 full-year result was $3.7 million, up 131.58% from the prior year.
  • Other Operating Expenses advanced to $1.3 million in Q2 2026 per IVVD's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $17.8 million in Q4 2022 and bottomed at -$600000.0 in Q4 2023.
  • Historically, Other Operating Expenses has averaged $2.4 million across 5 years, with a median of $829500.0 in 2023.
  • The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 103.38% in 2023, then soared 678.41% in 2025.
  • Over 5 years, Other Operating Expenses stood at $17.8 million in 2022, then slumped by 103.38% to -$600000.0 in 2023, then jumped by 220.67% to $724000.0 in 2024, then soared by 57.46% to $1.1 million in 2025, then climbed by 11.67% to $1.3 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $1.3 million, $1.1 million, and $1.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 685,000.00
Mar 31, 2025 834,000.00
Dec 31, 2024 724,000.00
Sep 30, 2024 806,000.00
Jun 30, 2024 88,000.00
Dec 31, 2023 -600,000.00
Sep 30, 2023 4.60 Mn
Jun 30, 2023 150,000.00
Mar 31, 2023 825,000.00
Dec 31, 2022 17.77 Mn
Sep 30, 2022 4.00 Mn
Sep 30, 2021 4.00 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 1.00 Mn